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Abstract
Human-wildlife conflicts, a growing and sad reality worldwide, makes population control of wildlife and feral animals 
one of the biggest challenges in wildlife management, especially due to the rapidly expanding human population, 
and consequently the ever-diminishing natural habitats of animals. Human activities and the destruction of nature 
forcing wildlife to move inevitably into urban and agricultural areas, causing “conflicts”, such as the risk of zoonosis 
and traffic accidents, as well as damage to crops in the search for food, whose losses reach millions of dollars. For 
decades, science has been engaged in extensive efforts to develop methods of “humane” population control methods, 
and many techniques are being employed in order to control wildlife population. In this article, we present an overview 
of applied contraceptive methods with simplified graphic demonstrations of their interactions with reproductive 
physiology, furthermore relating pros and cons of used antifertility agents. These are being compared to a set of desired 
characteristics for free-ranging wildlife for in-field applications, with emphasis on reversible immunocontraception – 
concluding, therefore, the reasons why this concept is becoming the most appropriate and promising for free-ranging 
wildlife.
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Resumo
Os conflitos envolvendo humanos e animais selvagens são uma realidade crescente e triste no mundo inteiro, 
tornando o controle populacional da fauna silvestre e de animais ferais o maior desafio, principalmente diante do 
crescimento da população humana e, consequentemente, da diminuição dos habitats naturais dos animais. As 
atividades humanas e a destruição da natureza forçam os animais de vida livre a se dirigirem para áreas urbanas e 
agrícolas, o que inevitavelmente causa conflitos, como o risco de zoonoses, acidentes de trânsito, bem como danos 
às plantações, quando em busca de alimentos, cujo prejuízo chega a milhões de dólares. Durante décadas, a ciência 
esteve empenhada em esforços extensivos para desenvolver métodos de controle populacional “humano”; e muitas 
técnicas foram utilizadas para controlar as populações de animais silvestres. Neste artigo será apresentada uma visão 
geral dos métodos anticoncepcionais aplicados, com demonstrações gráficas simplificadas de suas interações com 
a fisiologia reprodutiva, bem como relacionando os prós e os contras dos agentes antifertilidade empregados; eles 
serão comparados com um conjunto de características desejadas para as aplicações em fauna a campo, com ênfase em 
imunocontracepção reversível, demonstrando, portanto, as razões pelas quais esse conceito se torna o mais apropriado 
e promissor para animais silvestres de vida livre.
Palavras-chave: Controle de população animal silvestre. Conflitos humanos-animais selvagens. Mamíferos. 
Imunocontraceptivos reversíveis.
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Introduction
The biggest challenge in understanding wildlife 
reproductive physiology lies within its vast diversity of 
species. Just in the mammalian class alone, there are more 
than 5500 known species (INTERNATIONAL UNION 
FOR CONSERVATION OF NATURE, 2009), every single 
one with its anatomical and biological particularities. 
Any campaign to manipulate a species population by 
employing contraceptive methods demands a dedicated 
understanding of its reproductive physiology and social 
makeup to warrant the overall health and well-being of 
the individual animal as well as of its entire group. Which 
contraceptive method to choose depends on several 
aspects, ranging from the species to be treated, gender, 
age, and reproductive biology to environmental situations, 
among many others, and there is no “one-product-fits-
all” solution. Moreover, most contraceptive products 
are developed and optimized for human use, and almost 
exclusively for women. Although approved by regulatory 
authorities, and tested for safety and efficiency, there are 
still many reported adverse effects in humans, let alone 
potential health concerns in wildlife species. Modern 
contraceptives can manipulate biological processes 
at any point of the reproductive process, for instance 
preventing hormone synthesis at the hypothalamus and 
pituitary glands by hindering receptor expression or by 
blocking receptors, ceasing gametogenesis, impeding 
sperm motility, or blocking sperm-ovum diffusion, just to 
name a few (DELVES et al., 2002; ASA, 2005; COOPER; 
LARSEN, 2006; PICKARD; HOLT, 2007; KIRKPATRICK, 
2011; KAUR; PRABHA, 2014; KOGAN; WALD, 2014).
But why is wildlife population control even an issue? 
Mainly, it is an attempt to control and minimize human-
wildlife conflicts, such as urban invasions, agricultural 
destructions, attacks on livestock and humans, besides the 
spread of zoonotic diseases, among others. Moreover, it 
is also important for land management, or due to space 
limitation in captivity, as well as the noble efforts to guarantee 
species survival, where genetic variance comes into play.
This review attends to the understanding of the 
dynamics of contraceptive methods and its interactions 
with the mammalian reproductive physiology and 
endocrinology, as well as associated adverse impacts. 
Emphasis is given on immunocontraceptive concepts, 
illustrating the attributes that make this strategy, for the 
time being, perhaps the most practicable alternative to 
control free-ranging wildlife population.
Briefly: the hypothalamic-pituitary-gonadal 
axis (HPG axis)
Even though the hypothalamus, the pituitary, and the 
gonadal glands are distinct entities, in their performance of 
controlling the reproductive function (among several other 
duties) they work together and depend on one another. The 
hypothalamus, an organ that regulates many homeostatic 
functions and responds to ambient influences (stimuli), drives 
many physiological and behavioral processes. To illustrate: a 
male perceives a female in heat by sensing her pheromones; 
sight and physical contact are all stimuli that trigger the 
male’s sexual behavior, exhibited by fights between males 
for dominance and mating rights, urging sexual arousal, 
mounting, intromission, and ejaculation. The pituitary gland, 
or hypophysis, is divided into three lobes: the anterior, or 
adenohypophysis (adeno = relating to gland), the intermediate, 
and the posterior lobe, synthesizing and secreting hormones 
responsible for the regulation of a wide range of physiological 
functions. Concerning reproduction, the gonadotropins 
Luteinizing Hormone (LH) and the Follicular Stimulating 
Hormone (FSH) from the adenohypophysis, regulated by the 
hypothalamic Gonadotrophin-releasing Hormone (GnRH), 
are the chief reproductive hormones. These two glands are 
connected by the hypophyseal portal system that supplies 
the blood and therefore the passageway for hormones. The 
hormones GnRH, LH, and FSH are identical in male and 
female mammals, with the same general regulatory role of 
gonadal activities (Figure 1), which is stimulating sex hormone 
synthesis and gametogenesis, although this is not their only 
function. These hormones are one of the principal targets 
regarding contraceptive agents and their applicability in both 
sexes. Reproductive hormones follow a very precise hierarchy, 
or pathway, referred to as the hypothalamic-pituitary-gonadal 
axis (HPG-axis), which functions like a cascade. Nonetheless, 
that does not imply a one-way signaling street only, as 
regulatory messengers do also travel in the opposite direction, 
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called a positive or negative feedback loop, controlling the 
continuation of hormone synthesis and secretion. In males, 
the HPG axis and feedback control are significantly simpler 
than in females, for obvious reasons (not having estrous cycles, 
pregnancy, and birth). During Positive Feedback, the GnRH 
stimulates the release of gonadotropins, and subsequently LH 
and FSH stimulate Testosterone (T) synthesis mainly within 
the testis and spermatogenesis. During Negative Feedback, 
triggered by an increased plasma concentration of inhibin 
and peak T concentrations, secreted by the Sertoli and Leydig 
cells respectively, causes an inhibition of GnRH, LH, and 
FSH secretion; it is further believed that estrogen also plays 
a regulatory role in testosterone production (ABNEY, 1999; 
PINEDA et al., 2003; NELSON, 2005; CUNNINGHAM; 
KLEIN, 2007; JOHNSON, 2013).
In females, feedback signaling is more complex, as 
it depends on the different phases of the estrous cycle 
(Figure 2); though distinct events, they depend on each 
other. In most mammalian species, leading from the 
follicular phase to ovulation and to the luteal phase 
is only interrupted by pregnancy or cessation of the 
ovarian activity either by menopause, pathology, adverse 
ambient conditions, chronic stress, or suppression by 
contraceptive methods.
Figure 1 –  Simplified representation of the male’s Hypothalamic-Pituitary-Gonadal (HPG) axis and reproductive feedback loops. 
Grey fields, location of hormone receptors and synthesis; Green fields reproductive hormones. Green arrows: positive 
feedback loop (stimulatory) and red arrows: negative feedback loops (inhibitory). 
Source: adapted from Mac Hadley and Jonathan Levine (2007) and Rosenfield (2016)
Feedback-loops during follicular phase: positive 
feedback – GnRH stimulates the secretion of LH and FSH, 
which in turn drive the ovarian follicle growth; negative 
feedback – the ovarian follicles synthesize and secret 
Estradiol (E2). After reaching peak concentrations, GnRH 
decreases, keeping LH and FSH secretion to a minimum.
During ovulation: positive feedback only – continuous 
release of GnRH maintains LH and FSH secretion, triggering 
ovarian follicle growth and eventually leading to the formation 
of dominant or matured follicle(s), starting to produce E2, 
subsequently liberating an oocyte. Initially secreted E2 also 
promotes thickening and vascularization of the endometrium.
During luteal phase: positive feedback – after ovulation, 
the follicle tissue, under the influence of LH, transforms into 
a corpus luteum (CL), and together with FSH maintains 
estrogen secretion; negative feedback – The CL starts to 
secrete the progesterone (P4). Increased plasma levels of 
P4 and E2 will act on the hypothalamus, as well as on the 
anterior pituitary, causing an inhibition of GnRH, LH, 
and FSH, driving down follicle activity as, simultaneously, 
endometrial lining develops, preparing the uterus for 
potential pregnancy (NUSSEY; WHITEHEAD, 2001; 
PINEDA et al., 2003; FELDMAN; NELSON, 2004; NORRIS; 
CARR, 2013; SQUIRES, 2013).
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Figure 2 – Female HPG-axis and feedback loops, depending on the phase of the estrous cycle
Source: adapted from Mac Hadley and Jonathan Levine (2007) and Rosenfield (2016)
Ligands and receptors: the “key” to unlock 
contraceptive mechanisms
Hormones, neurotransmitters, and pheromones are 
examples of ligands, because of their binding activity with a 
specific receptor protein, located either on the surface of the 
cell, within the cytoplasm, or in the nucleus. Specific means 
that a ligand molecule must “fit” the receptor like a key in a 
lock, and the better it does (rate of binding), the better the 
response. A binding prompts the receptor to a conformational 
change (shape), initiating the cell’s signaling cascade, 
leading to a cell response. The biggest pharmacological 
challenge is to design a perfect ligand that only binds to 
its designated receptor. Pharmacological development 
is human-market driven, leaving the development for 
wildlife species-specific contraceptives a low priority, if at 
all, and its focus of application lies with domestic animals, 
leaving for wildlife management only what is generally 
obtainable, steroid hormone-based contraceptives being 
the most common and most frequently used. Nevertheless, 
as relayed by numerous published studies, these methods, 
depending on the species, carry a bad reputation for 
serious side effects, provoked by unwanted activation of 
non-target receptors, causing several physiological and 
behavioral side effects, especially in carnivore species. A 
typical example: in female synthetic androgens may bind 
to P4 receptors, mimicking progesterone-like cell signaling, 
consequently modulating endometrium function, leading 
to uterine pathologies; or synthetic P4s, known to induce 
hypersecretion of growth hormones, responsible for the 
development of cystic endometrial hyperplasia (LODISH, 
2000; BHATTI  et  al.,  2007; MORESCO et al., 2009; 
GREGOIRE, 2013; ASA et al., 2014).
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Before a ligand can bind to a cell, its receptors must be 
adequately expressed (quantity) to bring about a biological 
effect, which depends on the physiological necessity. In 
some processes, the cell undergoes a “priming”, or up-
regulating, describing the event of amplifying the number 
(expression) of receptors. Inverse to that, there is “down-
regulation”, or a reduction of receptors.
An example of a contraceptive-driven down-
regulation, or desensitization
GnRH-stimulated gonadotropin secretion may be 
inhibited by using GnRH antagonists (physically blocking 
the receptor), or by application of a GnRH agonist (GnRH 
analog) that due to constant exposure may provoke 
desensitization (inactivation of receptors), or by down-
regulation (decreased receptor expression), ultimately 
resulting in reduced gonadal activity. Noteworthy, in the case 
of a GnRH agonist there is an initial “paradoxical” response, 
a flare effect, exhibiting an increase in plasma LH and FSH 
levels, followed by a sharp decrease (FINCH et al., 2009).
Male reproductive physiology under the 
influence of contraceptives
In males, the primary reproductive organs are the 
testes, responsible for steroid genesis and spermatogenesis, 
controlled by LH and FSH secreted in a pulsatile pattern and 
regulated by the positive feedback of GnRH and the negative 
feedback of Testosterone (Figure 3). Testosterone, the chief 
testicular androgen, is synthesized from cholesterol, primarily 
within the Leydig cells of the testes. However, its synthesis 
also occurs in other organs, such as the adrenal cortices in 
both sexes and in female ovarian theca cells, in the placenta 
during pregnancy, and even in the skin (ZOUBOULIS, 2009). 
Testosterone’s first androgenic effects take place during sexual 
differentiation in the developing fetus, during maturation 
of the male sex organs, during growth and puberty, and 
throughout adulthood to sustain spermatogenesis – plus, 
its bearing on the development and maintenance of 
secondary sexual characteristics, physical and behavioral 
(aggression). In fact, many studies investigate antifertility 
drugs to control intramale aggression, a dilemma in several 
captive-held species (PENFOLD et al., 2002; FERRIE et al., 
2011; RACHEL, 2012). Unfortunately, one of the undesired 
consequences is the negative effects on male adornments, 
meaning the lion’s mane; elk or deer antlers; bird’s plumage; 
scent-marking glands, like the nasal Morillo of capybaras, 
and muscular appearance. Estrogen, however, thought of as 
a female sex hormone, is being synthesized from Testosterone 
in the Sertoli cells, controlled by FSH, believed to play an 
inhibitory role in the secretion of Testosterone from the 
Leydig cell (ABNEY, 1999). Likewise, there are several other 
cell-signaling molecules being produced and co-regulating 
Testosterone synthesis. Sertoli cells also secrete a transport 
protein, called androgen-binding protein, important in its 
role to concentrate Testosterone in the seminiferous tubules 
and to carry it throughout the body (SIMPSON et al., 1999; 
PINEDA et al., 2003; CLARKE; POMPOLO, 2005; BERGER 
et al., 2007; CUNNINGHAM; KLEIN, 2007; MEAD et al., 
2007; REITER et al., 2009; ZOUBOULIS, 2009; TASSIGNY; 
COLLEDGE, 2010; ROTSTEIN, 2013).
Figure 3 –  Example of negative feedback signaling while under the influence 
of contraceptives
Source: adapted from Mac Hadley and Jonathan Levine (2007) and Rosenfield (2016)
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Persistent testosterone levels after chemical or 
surgical castration
We do know that successful inhibition of gametogenesis 
is achieved after castration, either chemical or surgical. 
We also understand that, despite castration, there is still a 
certain plasma testosterone level present, maintained by 
adrenal androgen synthesis. The question remains, though: 
does Testosterone synthesis from androgens other than 
the testis reach efficient plasma concentrations to have 
an impact on sexual/aggressive behavior or any other 
gender-specific characteristics? An important question 
if considering testosterone-depending behavioral traits, 
which govern social group dynamics such as establishing 
and maintaining the dominant hierarchical group 
structure, imperative for its very survival. This is the reason 
why in captive animals, in free-ranging individuals, or in 
smaller groups vasectomy is the contraceptive method of 
choice, allowing minute changes in the overall androgen 
plasma concentration. However, depending on species 
and physical location, it is not a feasible “in-the-field” 
alternative, especially on a greater scale (PINEDA et al., 
2003; CHESTER-JONES et al., 2013; NISHIYAMA, 2014).
Female reproductive physiology under the 
influence of contraceptives
Female endocrinology, in comparison, is far more 
complex because of the obvious: conception, embryo 
development, birth, and the nourishment of the newborn. 
The two principal female gonadal steroid hormones are 
estradiol (E2) and progesterone (P4), such as in males, 
synthesis and secretion are chiefly under the influence 
of GnRH and Gonadotropins. E2 is synthesized in the 
ovary’s theca interna and granulosa cells; controlled by 
positive feedback mechanism of LH and FSH, aided 
by Activin, and regulated by the negative feedback 
when E2 reaches peak plasma concentrations, acting 
on GnRH and Inhibin on FSH synthesis (Figure 4). 
Moreover, depending on the species-specific reproductive 
characteristics, such as being seasonal or non-seasonal 
breeders, mono- or polyestrous, and having spontaneous 
or induced ovulation, each has its unique endocrinological 
functioning. Similar to the male testosterone, estrogen is 
responsible for developing the female reproductive organs 
and for the maintenance of secondary sex characteristics, 
including sexual behavior (receptiveness for mating), 
also referred to as behavioral estrus. Another ovarian 
hormone is the Oocyte Maturation Inhibitor (OMI), 
responsible for the preservation of the oocytes during the 
arrest stage. Inhibin, like in males, blocks the secretion of 
FSH, while Gonadocrinin influences the steroid genesis in 
the theca cells (a layer of the ovarian follicles). In addition, 
Activin and Relaxin play their roles in ovarian activity 
and parturition, respectively. Ambient and physical 
conditions influence the female cyclicity, which is why 
contraceptive effects on the reproductive physiology can 
be complex and irregular (SIMPSON et al., 1999; PINEDA 
et al., 2003; CLARKE; POMPOLO, 2005; BERGER et al., 
2007; CUNNINGHAM; KLEIN, 2007; MEAD et al., 2007; 
REITER et al., 2009; ZOUBOULIS, 2009; TASSIGNY; 
COLLEDGE, 2010; ROTSTEIN, 2013).
Figure 4 – Example of hormonal changes during an estrous cycle, without contraceptive influences
Source: Pineda et al. (2003) and Rosenfield (2016)
Braz. J. Vet. Res. Anim. Sci., São Paulo, v. 55, n. 1, p. 1-16, 2018
| 7
Figure 5 – Estrus cycle under the GnRH-analog contraceptive influence
Source: Pineda et al. McDonald (2003) and Rosenfield (2016)
A simplified representation of estrus cycles under 
the influence of two types of contraceptives (Figure 5). 
GnRH analogue: the administration of a GnRH-
analog implant, resulting in an initial flare response 
of LH and FSH secretion, and subsequent sharp drop, 
until an inhibitory effect on gonadotropin secretion, 
as long as the GnRH implant maintains its bioactivity 
(FINCH et al., 2009).
Steroid-based contraception
Administration of the safer combo-contra-
ceptive, such as an estrogen and progesterone agent, 
functions basically by tricking the body into belie-
ving it is already pregnant. Plasma levels of estrogen 
and progesterone remain constant throughout the 
treatment (Figure 6), resulting in failure to produ-
ce an estrogen and LH peak, and consequently no 
ovulation occurs, with an added effect of preventing 
fertilization mechanically, through a thickening of 
the cervical mucus, interfering with sperm motility 
(MARTIN; BARBIERI, 2016).
Figure 6 – Estrus cycle under steroid-hormone contraceptive influence
Source: adapted from Pineda et al. (2003) and Rosenfield (2016)
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Contraceptive methods in wildlife population 
control
Not considering social and individual behavioral 
impacts, nor potential risks of adverse effects, contraceptive 
methods available for wildlife species may be divided into:
1) Reversible:
a)  physical separation: the oldest, easiest, safest, and 
cheapest method, if space requirement is of no 
concern;
b)  surgical procedures, examples: vasectomy in 
males – technically considered reversible, but that 
depends on several factors to be done so successful-
ly (in reality, however, and depending on the spe-
cies treated, occurrence of intensive inflammatory 
processes, and formation of scar tissue, there is a 
potential risk of non-reversibility); tubal ligation in 
females – under field conditions, all considered im-
practical, costly, often impossible and dangerous, 
especially with a larger number of animals to be 
treated;
c)  chemical contraception: exogenous hor-
mone-based contraceptives through oral, injection, 
or implant via for males and females, with steroid or 
non-steroid hormones;
d)  immunocontraceptive vaccines (male and fe-
male);
e)  chemical castration male and female depending on 
treatment duration, concentration, and the agent 
used, considered reversible in many cases;
f)  mechanical: by obstruction, such as the Vas Plugin 
males, or the IUDs and sponges, some in combina-
tion with hormone preparations for female applica-
tion.
2) Non-reversible:
a)  surgical procedures: orchiectomy (removal of the 
testis) for males and ovary-salpingo- hysterectomy 
(removal of the ovaries, fallopian tubes, and the 
uterus) for females.
Which contraceptive method should be employed at 
the end depends on the chosen strategy, regarding short or 
long-term effects, applicability in the field or in captivity, 
ease of administration, associated risks, logistic and costs 
involved, and, of course, the species.
The “perfect” contraceptive for wildlife species
Proposed desired attributes:
•  first and most importantly it should present no 
health risk for the individual;
•  with little impact on secondary sexual 
characteristics;
•  as little influence as possible on the individual 
and on the overall social group behavior;
•  In most circumstances, it is desired that it offers 
100% reversibility;
•  offering long-term anti-fertility effects;
•  applicable in both genders;
•  easy administration (especially long distance);
•  one-time (shot) only, meaning no refresher or 
booster needed;
•  economically feasible for any wildlife manage-
ment program;
•  regarding environmental considerations – it 
should not pass through the food chain;
•  it should not turn into a major pollutant (KIRK-
PATRICK; RUTBERG, 2001; LIU, 2011).
Hormone-based contraceptive agents
Antifertility drugs that act on the endocrine system 
are based either on steroid- or non- steroid (glycoprotein, 
peptide) hormones, and are mainly developed for human 
application, mostly for women. Because of their relative 
easy application, (orally, injected, or implanted), their 
efficiency, and not less important, relatively low costs, they 
are most commonly used in the treatment of domestic 
animals and captive wildlife (ASA; PORTON, 2005; 
PICKARD; HOLT, 2007; LIU, 2011; GARSIDE et al., 2014; 
ROSENFIELD, 2016). They may act at any given point 
along the hypothalamic–pituitary–gonadal axis, including 
feedback signaling. Either as an agonist or an antagonist, 
for example, inhibiting synthesis and secretion of GnRH, 
and subsequently LH/FSH hormones – consequently 
ceasing gonadal activities, such as sex-hormone synthesis 
and gametogenesis. They may also modulate the function 
of the female reproductive apparatus, bringing about 
desired contraceptive effects, like obstructing the transport 
of the ovum, blocking sperm passage and impending 
implementation of the egg on the endometrium. 
Nevertheless, steroid hormone-based contraceptives are 
very potent and may bind to non-target receptors. For 
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instance, a progestin may bind to an androgenic receptor 
(AR) and cause androgenic effects, or an estrogenic 
effect, by binding to estrogen α and β receptors (ER), 
possibly triggering several undesired cell responses, 
leading to serious side effects (DELIGDISCH,  2000; 
MUNSON  et  al.,  2002; PINEDA  et  al., 2003; 
ASA;  PORTON,  2005; MCALOOSE  et  al., 2007; 
DAVTYAN, 2012; ASA et al., 2014).
Most commonly used hormone contraceptives are 
progestin only, or progestin-estrogen combination, 
which require smaller dosages and are safer 
(SITRUK-WARE, 2006). As stated by Asa (2005), MGA 
(melengestrol acetate), a progestin, is the most commonly 
used contraceptive in US zoos, mainly due to its availability 
and effectiveness in a wide range of species.
As this article focuses on free-ranging wildlife mammals, 
intra-uterine devices are not being particularized, although 
frequently used in domestic and zoo environments.
The immune system: self, non-self, and the 
concept of vaccines
In general, the immunocontraceptive methods take 
advantage of the body’s immune system and its protective 
mechanism to discriminate, by identifying indigenous (self) 
and marking, attacking, and eliminating foreign (non-self) 
proteins, allowing to fight off infectious diseases. Non-self 
materials or antigens are being marked by the presence 
of antibodies – specific to a group of organisms, or very 
similar ones. When the body’s own defense mechanism 
acquires immunity, it is termed “active immunity” and may 
last many decades, even a lifetime. If provided by external 
means, it is called “passive immunity”, either introduced 
with the first milk given by the mother to the offspring 
(colostrum), or transplacental, or after being produced 
by a mammalian animal, harvested, and transferred as a 
vaccine, via bait or injection, to another animal. Although 
a very effective protection, its shortcoming is its limited 
temporary activity, lasting normally only a few weeks 
to months. However, today this is less of an issue, with 
the development of slow-release technologies, capable of 
providing protection that may last years. Even though the 
strongest immune response is with live microorganisms, 
these antigens do not need to be alive in order to trigger 
a response. For safety reasons, vaccines contain foreign 
inactivated or killed pathogenic microorganisms that 
mimic a real infection, but without the infection and 
associated complications.
The concept of immunocontraception provokes the 
production of antibodies against the antigen, binding to 
the body’s own reproductive protein, hormone, or receptor 
(autoimmune response), either causing a barrier, or the 
formation of large molecular structures (change of protein 
structure = change of function), thus inhibiting their native 
role in the fertility mechanism as long as a sufficiently high 
concentration (titer) of antibodies is present (HERR, 1996; 
BARBER; FAYRER-HOSKEN, 2000; DELVES, 2004; 
TIZARD, 2009; MOSER; LEO, 2010; CROY, 2014).
The role of adjuvants
Besides the active ingredient, a vaccine is made up 
of adjuvants, (lat. adiucare: to aid), which are important 
additives to vaccines, improving the innate immune 
response (antibody and T lymphocyte) by increasing the 
inflammatory response as would a real infection, which 
in turn is important for an optimized adaptive immune 
response. Unfortunately, adjuvants are known to have their 
own set of potential health risks and are often associated 
with local injection-site reactions (LYDA et al., 2005; 
MUNSON et al., 2005).
Adjuvants may include organic components which may 
be liposomes, a spherical vesicle with a minimum of one 
lipid-bilayer, used as a vehicle for pharmaceutical drugs, 
lipopolysaccharides (LPS), part of endotoxins, parts of a 
bacterial cell walls, RNA, or DNA strands, alum (hydrated 
potassium aluminum sulfate), and emulsions (oil-in-
water/water-in-oil mixtures), such as Freund’s Incomplete 
Adjuvant (IFA).
Some adjuvants also function as a delivery system, 
causing the formation of depots at the injections site 
that traps the antigens, and allowing only a slow release 
of the vaccine components, maintaining a prolonged 
immunogenic stimulus while enhancing the overall 
immune response – a practice that allows “one-shot” 
(only one application), with long-term effects (ASA, 
2005; SITRUK-WARE, 2006; MILLER et al., 2008; 
REED et al., 2013).
Concepts of immunocontraception 
(immunological castration)
Following the most commonly studied and employed 
contraceptives methods: female only (PZP, Porcine 
Zona Pellucida), male only (Eppin, epididymal protease 
inhibitor), or female and male (anti-GnRH antibody), see 
Figure 7.
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Figure 7 – Overview immunocontraceptive targets
Source: adapted from Liu et al. (2005) and Rosenfield (2016)
Immunocontraceptive vaccine
A non-cellular membrane surrounds the 
mammalian ovum, consisting of several glycopro-
teins, known as the zona pellucida (ZP). The glyco-
protein ZP3 has been identified as the sperm-binding 
receptor (which permits the attachment of a sperma-
tozoon to the ovum, in order to continue the next step 
of the fertilization process, leading to the diffusion 
of the sperm into the oocyte, creating a zygote). The 
pZP vaccine is produced by creating a zona pellucida 
antigen derived from porcine oocytes. Once the fe-
male is inoculated with the PZP vaccine, her immune 
system will respond by producing antibodies against 
the pig’s oocyte antigen. The very same antibodies 
also bind to the sperm receptors on the ovum’s surfa-
ce (Figure 8), which will cause a distortion of the egg 
structure, thereby blocking sperm attachment, ren-
dering the egg infertile without any other side effects 
or behavioral impacts (MILLER et al., 2001; LIU et 
al., 2005; KIRKPATRICK et al., 2010).
Braz. J. Vet. Res. Anim. Sci., São Paulo, v. 55, n. 1, p. 1-16, 2018
| 11
Figure 8 – PZP Vaccine; ZP sperm-binding receptors with and without anti-zona antibodies
Source: adapted from Liu et al. (2005) and Rosenfield (2016)
The mechanism of the GnRH 
immunocontraceptive vaccine
The synthetic GnRH peptide is coupled to a foreign 
protein, like a hemocyanin protein, purified from the 
hemolymph of limpets (aquatic snails), together with a 
killed pathogenic microorganism, to enhance antigenicity. 
The elicited antibodies in this autoimmune response now 
mark native (self) GnRHs, forming large antibody-GnRH 
complexes. The inhibitory mechanism is not completely 
elucidated, offering two assumptions: (i) the newly formed 
protein complex has dimensions too large to diffuse through 
the capillary membrane of the hypophyseal portal system, 
thus not being able to reach GnRH receptors for LH and 
FSH synthesis at the adenohypophysis; and (ii) the GnRH-
Antibody structure prevents binding to corresponding 
GnRH receptors in the pituitary gland, consequently 
inhibiting gonadotropin secretion, ultimately preventing 
sex hormone synthesis and gametogenesis (Figure 9) 
(FAGERSTONE, 2006; MASSEI et al., 2008; MILLER et 
al., 2008; GRAY et al., 2010; SHARMA et al., 2014).
Figure 9 – GnRH Mechanism; normal and inhibited by anti-GnRH antibodies
Source: adapted from Pineda et al. (2003)
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The concept of immunocontraception: almost 
perfect for wildlife application?
Although several articles mention 
immunocontraception as a “truly novel” concept, it is 
not quite the case, as first studies using the body’s own 
immune system as an antifertility method started in 
the early 1930s (BASKIN, 1932). In-field application, 
procedures that require prior capture, tranquilization, 
and invasive procedures like implants, tubal ligation, 
and vasectomy are less feasible, but, of course, there are 
exceptions. Moreover, antifertility vaccines that require 
booster dosages are not practical.
Discussion
In order to choose between the immunocontraceptive 
of PZP or GnRH vaccines depends on the overall strategy 
on population control of a specific species, whether the 
targets are female, male, or both, among other factors. 
Unfortunately, there is no population control without 
having any impacts on the individual or the group. 
Specially in species with strong hierarchic social structures, 
targeting dominant males or females for contraception will 
have an intensive impact on the group’s social behavior, 
perhaps even serious implications for its survival. The aim 
of free-ranging wildlife/feral population control is to avoid 
or minimize human-wildlife conflicts, and circumventing 
senseless killings, therefore leaving preoccupation about 
social impacts in second place. Anti-GnRH vaccines are 
not perfect, and there are real concerns about its use; 
nevertheless, recalling the wish-list’s criterions, for the 
time being, what else is there?
• employable in both genders;
• “one-shot” only;
• highly effective (depending on species);
• long-term contraceptive effects (month to years, also 
depending on the species);
• very few adverse effects known (physiologic);
• no observed impacts on secondary sexual 
characteristics (lack of long-term studies);
• safe and quick administration (perfect for long-
distance);
• last, but not least, reasonable cost to benefit ratio.
Conclusion
Research conducted on traditional contraceptive 
methods, steroid hormone and non-steroid hormone 
agents show important improvements, mainly by offering 
newer generations and combinations of synthetic steroid 
hormones that require smaller concentrations, hence, 
fewer side effects. Nevertheless, hormone treatments are 
problematic when it comes to the application in wildlife 
species, although still the most frequently used when it 
comes to population management for captive wildlife. 
Non-steroid hormones seem to be the next best alternative, 
as they offer long-term infertility effects with fewer health 
risks and provide better functionality when it comes to 
application in free-ranging as well as captive wildlife.
Immunocontraception is by far the most studied 
subject and scrutinized infertility method for domestic, 
free-ranging wildlife and feral species over the last ten 
years, for several before-mentioned reasons. Numerous 
empirical studies proved repeatedly its effectiveness in 
rendering various species infertile for extended periods of 
time, as stated by Miller (2009) in some cases up to 7 years. 
Unfortunately, in many studies investigating reversibility 
was not always available due to time constraints. Observed 
adverse effects were rare and, if apparent, none were severe. 
Most frequent adverse effects were vaccine-injection 
site injuries and the development of some persistent 
granulomas, due to extensive inflammatory reactions to 
the adjuvants, considered a necessary “evil”, allowing to 
stimulate the immune response effectively enough while 
providing the slow-release effect, keeping the antibody titer 
adequately high, also maintaining contraception without 
the need for “booster” applications.
Looking at current and future research efforts, 
apparently, the focus stays on immunocontraceptives, with 
some promising new concepts to follow.
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